Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
 
Sign in
Join now
Dipesh Navsaria MPH, MSLIS, MD
Dipesh Navsaria MPH, MSLIS, MD Advisory Board
Irene Hamrick MD, FAAFP, AGSF, CMD
Irene Hamrick MD, FAAFP, AGSF, CMD Advisory Board
Jonathan Temte MD, PhD
Jonathan Temte MD, PhD Advisory Board
See All Experts
featured
Published in Primary Care and
1 other channel

Journal Scan / Research · February 03, 2022

Immunogenicity and Reactogenicity of Vaccine Boosters After Ad26.COV2.S Priming

The New England Journal of Medicine

 

 Save  Recommend
 Share

Additional Info

Disclosure statements are available on the authors' profiles:

Peter Lin MD, CCFP

The New England Journal of Medicine
Immunogenicity and Reactogenicity of Vaccine Boosters after Ad26.COV2.S Priming
N. Engl. J. Med 2022 Jan 19;[EPub Ahead of Print], RSG Sablerolles, WJR Rietdijk, A Goorhuis, DF Postma, LG Visser, D Geers, KS Schmitz, HM Garcia Garrido, MPG Koopmans, VASH Dalm, NA Kootstra, ALW Huckriede, M Lafeber, D van Baarle, CH GeurtsvanKessel, RD de Vries, PHM van der Kuy

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Most Read This Week

Recently Updated